Atanse

Website http://www.atanse.com

Founded 2010

Employees 3

Overview

Atanse enables the treatment of devastating neurological diseases through pioneering drug delivery technology. We strive to develop neurosurgical instruments that provide the greatest precision while minimizing the trauma associated with injections in the brain. Our lead product is designed to deliver regenerative therapies and is currently being used in a Phase 2 clinical trial to treat stroke patients with stem cells.

Video Pitch

Management Team

Director, Strategic Partnerships

Adam Leonard

Mr. Leonard is a serial entrepreneur who has led two medical device ventures through startup accelerator programs. He has a BS in Neuroscience from Brown University and is pursuing an MS in Engineering Management at Tufts University.

CEO

Michael Kelly

Mr. Kelly is an experienced engineer and entrepreneur, having bought and integrated seven companies and sold five. He has a BS/MS from the Massachusetts Institute of Technology and an MBA from Harvard University.

CSO

Miles Cunningham

Dr. Cunningham is the Director of the Laboratory for Neural Reconstruction at McLean Hospital and is affiliated with Harvard University Medical School. He has an MD from Harvard University and a PhD from the Massachusetts Institute of Technology.